Review of guidelines for bone mineral density testing and treatment of osteoporosis.

被引:37
|
作者
Lewiecki E.M. [1 ]
机构
[1] Osteoporosis Center, 300 Oak St. NE, Albuquerque, 87106, NM
关键词
Bone Mineral Density; Osteoporosis; Bone Mineral Density Testing; National Osteoporosis Foundation; United States Preventive Service Task Force;
D O I
10.1007/s11914-005-0014-x
中图分类号
学科分类号
摘要
Clinical practice guidelines (CPGs) are systematically developed statements intended to influence the behavior of health care providers and improve patient care. There are many CPGs with recommendations for selection of patients for bone mineral density testing and pharmacologic treatment of osteoporosis. Health care provider adherence rates for these CPGs are low. The multiplicity of osteoporosis CPGs directed to the same health care providers may play a role in their limited utilization in clinical practice. Similarities, differences, and conflicts in osteoporosis CPGs with wide distribution in the United States were examined. The analysis showed similarities as well as substantial variation in the patient populations addressed, inconsistency of some recommendations, differences in clinical risk factors identified, and sometimes limitations in clinical applications. If the number and diversity of osteoporosis CPGs is adversely affecting their use in clinical practice, then collaboration of stakeholder organizations to develop more consistent CPGs, in combination with systems-based approaches for their implementation, may improve patient care and reduce the burden of osteoporotic fractures.
引用
收藏
页码:75 / 83
页数:8
相关论文
共 50 条
  • [31] Effects of raloxifen on heel stiffness and axial bone mineral density in prevention of glucocorticoid induced osteoporosis.
    Frediani, B
    Allegri, A
    Baldi, F
    Bisogno, S
    Falsetti, P
    Storri, L
    Acciai, C
    Marcolongo, R
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S300 - S300
  • [32] Correlation between biochemical Markers(BAP and NTx) and bone mineral density in diagnosis of postmenopausal osteoporosis.
    Yang, SO
    Won, KS
    Kim, YS
    Lee, SH
    Ham, SY
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S366 - S366
  • [33] LONGITUDINAL CHANGES OF BONE MINERAL DENSITY AND BONE TURNOVER MARKERS IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS WITHOUT OSTEOPOROSIS.
    Caimmi, C.
    Rossini, M.
    Artuso, A.
    Tripi, G.
    Viapiana, O.
    Zanotti, R.
    Gatti, D.
    Adami, S.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S448 - S448
  • [34] Aleveolar bone density in an animal model of postmenopausal osteoporosis.
    Covell, DA
    Chung, H
    Macedo, B
    Harten, RD
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A468 - A468
  • [35] Patterns of bone mineral density testing - Current guidelines, testing rates, and interventions
    Morris, CA
    Cabral, D
    Cheng, HL
    Katz, JN
    Finkelstein, JS
    Avorn, J
    Solomon, DH
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (07) : 783 - 790
  • [36] Bone density measures and biochemical investigations in the management of osteoporosis.
    Dreux, Claude
    Menkes, Charles Joel
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2006, 190 (06): : 1275 - 1290
  • [37] Growth hormone increases bone mineral content in postmenopausal osteoporosis.
    Landin-Wilhelmsen, KLL
    Nilsson, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S222 - S222
  • [38] Effects of baseline active calcium absorption on bone mineral density (BMD) responses to calcitriol or calcium treatment in men with idiopathic osteoporosis.
    Ebeling, PR
    Yeung, S
    Poon, C
    Salehi, N
    Kotowicz, MA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S414 - S414
  • [39] Osteoporosis, bone mineral density and CKD–MBD: treatment considerations
    Jordi Bover
    Lucía Bailone
    Víctor López-Báez
    Silvia Benito
    Paola Ciceri
    Andrea Galassi
    Mario Cozzolino
    Journal of Nephrology, 2017, 30 : 677 - 687
  • [40] Chances in bone mineral density in subjects without osteoporosis treatment
    Anijar, JR
    Azevedo, E
    Lazarski, CFS
    Chahade, WH
    Soares, AH
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S36 - S36